Navigation Links
Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15
Date:7/24/2014

MUMBAI, India, July 24, 2014 /PRNewswire/ --

Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn

Business Highlights  

  • India Business grew by 20.87% to Rs. 3,971.59 Mn
  • US Business grew by 9.33% to Rs. 4,886.70 Mn
  • Rest of World (ROW) Business grew by 20.67% to Rs. 2,113.09 Mn
  • Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn
  • Latin America Business grew by 33.92% to Rs. 1,176.45 Mn

Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, today announced its results for the first quarter ended June 30, 2014.

     (Logo: http://photos.prnewswire.com/prnh/20130626/625083)

For the first quarter ended June 30, 2014, Glenmark's consolidated revenue was at Rs. 14,869.40 Mn (USD 248.61 Mn) as against Rs. 12,382.43 Mn (USD 221.91 Mn) in the corresponding quarter recording a growth of 20.08%. Consolidated EBITDA grew by 38.16% to Rs. 3423.32 Mn from Rs. 2477.82 Mn in the quarter. The consolidated Net Profit was at Rs. 1848.46 Mn for the quarter ended June 30, 2014 as compared to Rs. 1286.76 Mn for the previous corresponding quarter registering an increase of 43.65%.

"We have delivered strong results backed by good performances by our India, Rest of the World, Europe and LATAM businesses. While we outperformed in the Indian Pharmaceutical market with a growth of over 20%; our Rest of the World business led by Russia and LATAM operations bounced back strongly in this quarter with growth rates of over 20% and 30%  respectively"; said Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals Limited. "We have been making steady progr
'/>"/>

SOURCE Glenmark Pharmaceuticals
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Glenmarks Consolidated Revenue Increases by 18.9% to Rs. 12551.9 Mn for Q2 FY12-13
2. Glenmarks Consolidated Revenue Increases by 33.96% to Rs. 13812.59 Million for Q3 FY 12-13
3. PipelineRx Completes Acquisition of Healthcare Connectivity Solutions Company Evolute Consolidated Holdings
4. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
5. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
6. Aethlon Medical Note: Fiscal Year Revenue Guidance
7. Bacterin Announces First Quarter 2012 Revenue of $7.8 Million, Up 29% Year-over-Year, on Gross Margins of 76%, and 34% Reduction in Operating Loss
8. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
9. SynCardia Posts Record Revenue and Profit in Q1 2012
10. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
11. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Bayer HealthCare (Bayer) has entered ... (NASDAQ: ISIS ) on ISIS-FXI Rx, an ... of thrombosis. Under the agreement Bayer will further develop ... unmet medical need. As part of the clinical development ... ISIS-FXI Rx in an appropriate patient community. ...
(Date:5/4/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has ... (Bayer) to develop and commercialize ISIS-FXI Rx for ... agreement, Isis is eligible to receive up to $155 ... up-front payment and a $55 million payment upon advancement ... patients with compromised kidney function. Isis is also eligible ...
(Date:5/4/2015)... , May 4, 2015  FireflySci Inc., the newest member of the cuvette manufacturing ... they have turned the cuvette industry on its head by offering scientists amazing support for their ... Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3
... PharmaTech (Cayman) Inc. (NYSE: WX ), a ... with operations in China and the United States, today ... second quarter of 2011 after the New York Stock ... be Thursday morning, August 11, 2011 Shanghai time). The ...
... RAPIDS, Mich., July 19, 2011 ... rehabilitation and software services that benefit patients, healthcare ... to its multi-state group of outpatient clinics.  Agility ... the Company,s Michigan-based outpatient clinic presence to 23 ...
Cached Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 2Agility Health Expands National Outpatient Clinic Group with New Michigan Facility 2
(Date:5/4/2015)... California (PRWEB) May 04, 2015 In ... holistic treatment for substance absue, Per Wickstrom, the founder ... Entertainment’s EcoLuxe Lounge and the “Salute to the ... Stardust Penthouse on the top floor of the luxurious ... Los Angeles’ top producer of sustainable product placement in ...
(Date:5/4/2015)... New York (PRWEB) May 04, 2015 ... as $2.4 billion to settle thousands of Actos lawsuits ... diabetes medication increases the risk that a patient will ... on April 28th, if 95% of those eligible for ... resolve nearly 9,000 bladder cancer cases currently pending in ...
(Date:5/4/2015)... SAN DIEGO, California (PRWEB) May 04, 2015 ... health plans to manage their health is critical to ... patient satisfaction and reducing costs, but this will require ... spectrum. This change also demands that health systems move ... to speakers who took part in the third live ...
(Date:5/4/2015)... TROY Healthcare Solutions is proud to ... User Group (RUG) Conference in Baltimore, MD from May ... User Group provides an opportunity for clients to gather ... gallery. , In addition to sponsoring the event, TROY ... Atlantic RUG Conference. Attendees can stop by the TROY ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 The opportunity ... a full life are the motivating forces behind The Fairy ... clinical psychologist and author Amy L. Stark. , The inspiration ... little girl next door comes from Stark’s desire to be ... “I’ve been a fairy godmother to my neighbors’ children since ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2
... N.J., July 31 Smart Balance Inc.,(Nasdaq: ... organization,today. Richard McWilliams has been named to the ... reporting to Gregory Venner, executive,vice president and chief ... marketing efforts for the Company,s core brands., ...
... (NASDAQ: TOMO) announced today that it has extended its reach in ... installed in Scandinavia, at Lund University Hospital in Sweden. ... ... -- Jef Van Dam, general manager of TomoTherapyEMEA, said, "TomoTherapy ...
... July 31 HealthSouth,Corporation (NYSE: HLS ... wholly owned,subsidiaries, its previously announced purchase of ... inpatient rehabilitation hospital in,Vineland, NJ, from The ... of South Jersey, under the outstanding,leadership of ...
... are a common method for advertising food products. According ... food advertisements have a powerful influence on its viewers, ... adulthood has been shown to be a time for ... smoking and alcohol use and decreases in physical activity ...
... provides Aurora with technology and sensor standardization across ... facilities - creating efficiencies and cost savings, ... Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse,Oximetry, announced that Aurora ... SET pulse oximetry technology. The integrated health,care provider ...
... CAMBRIDGE, Mass., July 31 HIV/AIDS and health ... as Director for the Health,Systems 20/20 project in ... of Global Health,s flagship project working to strengthen ... the financing,governance, operational, and capacity constraints to further ...
Cached Medicine News:Health News:Smart Balance Announces Marketing Organization Appointment 2Health News: Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments 2Health News: Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments 3Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 3Health News:Watching too much TV is causing some university students to pack on the pounds 2Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 5Health News:Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project 2
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field....
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity ...
Inquire...
Medicine Products: